Tibena Everything Multi Cushion Spf50

For photoprotection, Homosalate is used topically in concentrations ranging from 5% to 15%.

• Application: Apply a generous amount (approximately 2mg/cm² of skin, or the 'shot glass' rule for the whole body) 15 to 30 minutes before sun exposure.
• Reapplication: Reapply at least every two hours, or more frequently after swimming, sweating, or towel drying.

• Infants under 6 months: The FDA and American Academy of Pediatrics (AAP) generally recommend avoiding the use of chemical sunscreens like Homosalate. Consult a pediatrician for guidance on sun-protective clothing and shade.
• Children over 6 months: Apply topically following adult instructions, ensuring the product is labeled for pediatric use to minimize irritation.

Renal Impairment

No specific dosage adjustments are currently recommended for patients with kidney disease due to the primarily topical nature of the drug; however, patients with severe renal failure should consult their doctor regarding systemic absorption concerns.

Hepatic Impairment

No specific adjustments are required for liver impairment, though the metabolism of absorbed Homosalate occurs via esterases which are ubiquitous in the body.

Elderly Patients

Elderly patients with thinned skin (atrophy) may experience higher rates of systemic absorption and should monitor for localized skin reactions.

Homosalate-containing products are for external use only. Do not ingest. Avoid contact with eyes, nostrils, and mouth. If the product is a spray, do not inhale the vapors; spray into hands and then apply to the face.

If you forget to apply Homosalate before sun exposure, apply it as soon as you remember. Note that protection is not retrospective; skin damage may have already occurred during the unprotected interval.

Acute systemic toxicity from topical application is highly unlikely. However, accidental ingestion can lead to salicylate poisoning. Symptoms include nausea, vomiting, dizziness, and tinnitus (ringing in the ears). In case of ingestion, contact a Poison Control Center or seek emergency medical care immediately.

> Important: Follow your healthcare provider's or the product label's dosing instructions. Do not adjust your usage frequency without medical guidance.

• Mild Skin Irritation: Redness or a slight stinging sensation immediately after application, which usually resolves within minutes.
• Oily Skin Residue: Because Homosalate is an oil-soluble liquid, it may contribute to a greasy feeling on the skin or exacerbate acne (comedogenicity) in predisposed individuals.

• Contact Dermatitis: An itchy, red rash that develops hours or days after application in individuals with a salicylate sensitivity.
• Folliculitis: Inflammation of the hair follicles, often appearing as small red bumps, particularly in areas with significant body hair.

• Photoallergy: An allergic reaction that only occurs when the skin, with the chemical present, is exposed to sunlight.
• Severe Allergic Reaction: Hives, swelling of the face or tongue, or difficulty breathing.

> Warning: Stop using Homosalate and call your doctor immediately if you experience any of these.

• Anaphylaxis: Though extremely rare for this ingredient, signs include rapid pulse, fainting, and swelling of the throat.
• Severe Chemical Burn: Blistering or peeling of the skin after application.
• Systemic Toxicity: If ingested, look for signs of salicylate toxicity such as rapid breathing (hyperventilation) or confusion.

Research into the long-term effects of Homosalate is ongoing. Some in vitro (test tube) studies suggest that Homosalate may have weak estrogenic or androgenic activity, potentially acting as an endocrine disruptor. However, clinical significance in humans at standard topical doses has not been definitively established by the FDA as of 2024.

No FDA black box warnings for Homosalate. It is generally considered safe for topical use under current OTC monographs.

Report any unusual symptoms or persistent skin changes to your healthcare provider.

Homosalate is intended for topical application only. While it is effective at preventing UVB-induced damage, it should be used as part of a comprehensive sun protection strategy that includes wearing hats, sunglasses, and seeking shade. Patients with known sensitivities to aspirin or other salicylates should exercise caution, as cross-reactivity is possible.

No FDA black box warnings for Homosalate.

• Allergic Reactions: Individuals with a history of contact dermatitis or sensitive skin should perform a "patch test" (applying a small amount to the inner forearm) before widespread use.
• Endocrine Concerns: Patients with hormone-sensitive conditions should discuss the use of chemical filters with their endocrinologist, given the data regarding potential receptor interactions.
• Inhalation Risk: When using spray formulations, there is a risk of lung irritation. Always apply in a well-ventilated area.

There are no standard laboratory monitoring requirements (like blood counts or liver tests) for the routine use of Homosalate. However, dermatologists may monitor patients with chronic skin conditions for signs of sensitization or worsening of underlying dermatitis.

Topical Homosalate does not affect the ability to drive or operate machinery.

There are no known interactions between topical Homosalate and alcohol consumption.

If a rash or irritation develops, discontinue use immediately. There is no withdrawal syndrome associated with stopping Homosalate-containing products.

> Important: Discuss all your medical conditions and skin sensitivities with your healthcare provider before starting a regimen containing Homosalate.

There are no documented drug-drug contraindications where Homosalate must NEVER be used. However, it should not be applied to broken or denuded (peeled) skin, as this significantly increases systemic absorption.

• Topical Retinoids (e.g., Tretinoin, Adapalene): Using Homosalate-containing sunscreens alongside prescription retinoids may increase skin sensitivity or irritation. While not prohibited, patients should monitor for excessive dryness or peeling.
• Benzoyl Peroxide: Some studies suggest that certain chemical UV filters may degrade in the presence of oxidizing agents like benzoyl peroxide, potentially reducing the efficacy of the sunscreen.

• Aspirin (Systemic): Since Homosalate is a salicylate, there is a theoretical (though clinically low) risk of additive effects in patients already taking high-dose aspirin, particularly if the sunscreen is applied over large surface areas frequently.

There are no known food or beverage interactions with topically applied Homosalate.

• St. John's Wort: This supplement increases photosensitivity. While Homosalate provides protection, the combination may still lead to unexpected sun-induced skin reactions.

Homosalate is not known to interfere with standard blood or urine laboratory tests. However, if systemic absorption is high, it could potentially lead to false-positive results in specific salicylate screenings, though this is not common in clinical practice.

> Important: Tell your doctor or pharmacist about ALL medications, supplements, and skin-care products you are currently using.

1. 1Salicylate Allergy: Patients with a known hypersensitivity to salicylates (including aspirin) should avoid Homosalate, as it can trigger allergic contact dermatitis or systemic allergic reactions.
2. 2Broken or Damaged Skin: Do not apply to skin with open wounds, severe burns, or active infections, as this bypasses the skin barrier and increases the risk of toxicity.

• Eczema/Atopic Dermatitis: Patients with compromised skin barriers may be more prone to irritation from chemical filters and may prefer physical blockers like Zinc Oxide.
• Pregnancy/Nursing: While not strictly contraindicated, some individuals choose to avoid Homosalate due to concerns regarding systemic absorption and endocrine activity.

There is a risk of cross-sensitivity between Homosalate and other salicylate-containing compounds, such as Octisalate or Trolamine Salicylate. If you have reacted to one, you may react to others.

> Important: Your healthcare provider will evaluate your complete medical history and skin sensitivity before recommending products containing Homosalate.

Homosalate is not assigned a formal FDA pregnancy category (as it is an OTC monograph ingredient). However, research (Matta et al., 2020) has shown that Homosalate is absorbed systemically and can be detected in the blood. While there is no definitive evidence of teratogenicity (birth defects) in humans, pregnant individuals may wish to consult their obstetrician about using mineral-based sunscreens (Zinc Oxide or Titanium Dioxide) as an alternative.

Homosalate has been detected in human breast milk. The clinical significance for the nursing infant is unknown. The risk of infant exposure via skin contact with the mother's treated skin should also be considered. Discuss use with a lactation consultant or pediatrician.

Approved for use in children older than 6 months. For children under 6 months, the skin is more permeable and the surface-area-to-body-weight ratio is higher, increasing the risk of systemic absorption. Physical sun protection (clothing/shade) is preferred for this age group.

No specific restrictions exist for the elderly. However, older patients should be aware that age-related skin thinning may increase the likelihood of localized irritation or systemic absorption.

No dosage adjustments are defined, but since Homosalate metabolites are excreted renally, patients with end-stage renal disease should use the product with awareness of potential systemic accumulation.

No specific adjustments are required for patients with liver disease.

> Important: Special populations should always seek individualized medical assessment before using chemical UV filters.

Homosalate acts as a chemical filter that absorbs UVB radiation. The electronic structure of the salicylate ring allows it to absorb high-energy photons (290-320 nm). This absorption promotes the molecule to an excited state; as it returns to the ground state, it releases the energy as harmless heat. Additionally, its classification as an Adenosine Receptor Agonist suggests it may bind to A1, A2A, or A2B receptors, though the clinical impact of this on the skin's inflammatory response is a subject of ongoing research.

The onset of action for Homosalate is approximately 15-30 minutes (the time required for the product to form a protective film on the stratum corneum). The duration of effect is typically 2 hours, after which the chemical may degrade or be removed by environmental factors.

| Parameter | Value |

|---|---|

| Bioavailability | Systemically detectable (Topical) |

| Protein Binding | Unknown in humans |

| Half-life | Not fully characterized (Metabolites ~2-4 hours) |

| Tmax | ~2 hours post-application |

| Metabolism | Hydrolysis to Salicylic Acid |

| Excretion | Primarily Renal |

• Molecular Formula: C16H22O3
• Molecular Weight: 262.34 g/mol
• Solubility: Insoluble in water; highly soluble in lipids and alcohols.
• Description: A clear, colorless to light yellow liquid with a faint fatty odor.

Homosalate is a member of the salicylate family of organic compounds. It is grouped with other chemical UV filters like Octisalate and is often used in combination with Avobenzone (a UVA filter) to provide broad-spectrum protection.